An open-label, phase I, dose-escalation study of tumor necrosis factor-α (TNFerade™ biologic) gene transfer with radiation therapy for locally advanced, recurrent, or metastatic solid tumors

Anand Sharma, Sridhar Mani, Nader Hanna

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'An open-label, phase I, dose-escalation study of tumor necrosis factor-α (TNFerade™ biologic) gene transfer with radiation therapy for locally advanced, recurrent, or metastatic solid tumors'. Together they form a unique fingerprint.